LU86930A1 - Utilisation de gangliosides exogenes dens des maladies tumorales comme facteur de protection contre la toxite de medicaments antitumoraux - Google Patents
Utilisation de gangliosides exogenes dens des maladies tumorales comme facteur de protection contre la toxite de medicaments antitumoraux Download PDFInfo
- Publication number
- LU86930A1 LU86930A1 LU86930A LU86930A LU86930A1 LU 86930 A1 LU86930 A1 LU 86930A1 LU 86930 A LU86930 A LU 86930A LU 86930 A LU86930 A LU 86930A LU 86930 A1 LU86930 A1 LU 86930A1
- Authority
- LU
- Luxembourg
- Prior art keywords
- gangliosides
- mixture
- vincristine
- agent
- antineoplastic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT4820386 | 1986-06-30 | ||
| IT8648203A IT1208751B (it) | 1986-06-30 | 1986-06-30 | Possibile uso dei gangliosidi esogeni in malattie tumorali come fattore protettivo contro la neurotossicita' da farmaci antitumorali |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| LU86930A1 true LU86930A1 (fr) | 1987-11-11 |
Family
ID=11265194
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LU86930A LU86930A1 (fr) | 1986-06-30 | 1987-06-25 | Utilisation de gangliosides exogenes dens des maladies tumorales comme facteur de protection contre la toxite de medicaments antitumoraux |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US5229373A (el) |
| EP (1) | EP0251298B1 (el) |
| JP (1) | JPS6327434A (el) |
| AT (1) | ATE69381T1 (el) |
| AU (1) | AU601988B2 (el) |
| BE (1) | BE1000723A4 (el) |
| CA (1) | CA1314219C (el) |
| DE (2) | DE3774501D1 (el) |
| DK (1) | DK165621C (el) |
| ES (1) | ES2038621T3 (el) |
| FR (1) | FR2601248B1 (el) |
| GR (2) | GR871005B (el) |
| IL (1) | IL82944A (el) |
| IT (1) | IT1208751B (el) |
| LU (1) | LU86930A1 (el) |
| ZA (1) | ZA874597B (el) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1254280B (it) * | 1992-03-13 | 1995-09-14 | Fidia Spa | Composizioni farmaceutiche comprendenti monosialoganglioside gm1 o un suo derivato atte al trattamento della malattia di parkinson |
| US6765087B1 (en) * | 1992-08-21 | 2004-07-20 | Vrije Universiteit Brussel | Immunoglobulins devoid of light chains |
| DE4430041A1 (de) † | 1994-08-24 | 1996-02-29 | Milupa Ag | Allergieprotektive Formelnahrung |
| US5567684A (en) * | 1994-09-14 | 1996-10-22 | The Regents Of The University Of California | Synthetic ganglioside derivatives |
| MXPA04001831A (es) | 2001-08-29 | 2004-07-08 | Neose Technologies Inc | Nuevos derivados sinteticos de gangliosidos y composiciones de los mismos. |
| US7888331B2 (en) | 2003-03-06 | 2011-02-15 | Seneb Biosciences, Inc. | Ganglioside compositions and methods of use |
| CN102046151A (zh) * | 2008-03-26 | 2011-05-04 | 牛津大学 | 靶向内质网的脂质体 |
| US20120035120A1 (en) | 2009-03-25 | 2012-02-09 | Seneb Biosciences, Inc. | Glycolipids as treatment for disease |
| WO2011027344A2 (en) * | 2009-09-01 | 2011-03-10 | Hadasit Medical Research Services And Development Ltd. | Combination of vitamin e and beta-glycosphingolipids in compositions and methods for preventing and treating hepatic disorders |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1168205B (it) * | 1983-07-21 | 1987-05-20 | Wellcome Italia | Derivato di monsialo ganglioside dotato di attivita' antibatterica, antifungina ed antitumorale, composizioni che lo contengono e procedimento per la loro preparazione |
| IT1182209B (it) * | 1985-02-18 | 1987-09-30 | Fidia Farmaceutici | Uso terapeutico del monosialoganglioside gm1 e dei suoi derivati in gravi patologie di infarti cerebrali |
-
1986
- 1986-06-30 IT IT8648203A patent/IT1208751B/it active
-
1987
- 1987-06-22 IL IL82944A patent/IL82944A/xx unknown
- 1987-06-25 US US07/066,248 patent/US5229373A/en not_active Expired - Fee Related
- 1987-06-25 GR GR871005A patent/GR871005B/el unknown
- 1987-06-25 LU LU86930A patent/LU86930A1/fr unknown
- 1987-06-25 FR FR878708937A patent/FR2601248B1/fr not_active Expired
- 1987-06-25 ZA ZA874597A patent/ZA874597B/xx unknown
- 1987-06-26 BE BE8700719A patent/BE1000723A4/fr not_active IP Right Cessation
- 1987-06-29 DK DK333787A patent/DK165621C/da not_active IP Right Cessation
- 1987-06-29 AU AU74908/87A patent/AU601988B2/en not_active Ceased
- 1987-06-29 CA CA000540885A patent/CA1314219C/en not_active Expired - Fee Related
- 1987-06-30 JP JP62165131A patent/JPS6327434A/ja active Pending
- 1987-06-30 DE DE8787109415T patent/DE3774501D1/de not_active Expired - Lifetime
- 1987-06-30 DE DE19873721562 patent/DE3721562A1/de not_active Withdrawn
- 1987-06-30 EP EP87109415A patent/EP0251298B1/en not_active Expired - Lifetime
- 1987-06-30 ES ES198787109415T patent/ES2038621T3/es not_active Expired - Lifetime
- 1987-06-30 AT AT87109415T patent/ATE69381T1/de active
-
1992
- 1992-02-12 GR GR910402224T patent/GR3003790T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0251298A3 (en) | 1988-10-26 |
| FR2601248B1 (fr) | 1989-08-25 |
| FR2601248A1 (fr) | 1988-01-15 |
| DE3774501D1 (de) | 1991-12-19 |
| DE3721562A1 (de) | 1988-03-03 |
| JPS6327434A (ja) | 1988-02-05 |
| EP0251298B1 (en) | 1991-11-13 |
| GR3003790T3 (el) | 1993-03-16 |
| ZA874597B (en) | 1988-03-30 |
| GR871005B (en) | 1987-10-23 |
| EP0251298A2 (en) | 1988-01-07 |
| ATE69381T1 (de) | 1991-11-15 |
| US5229373A (en) | 1993-07-20 |
| DK165621B (da) | 1992-12-28 |
| AU601988B2 (en) | 1990-09-27 |
| ES2038621T3 (es) | 1993-08-01 |
| DK333787A (da) | 1987-12-31 |
| CA1314219C (en) | 1993-03-09 |
| AU7490887A (en) | 1988-01-07 |
| IT1208751B (it) | 1989-07-10 |
| BE1000723A4 (fr) | 1989-03-21 |
| IL82944A (en) | 1993-04-04 |
| DK165621C (da) | 1993-06-01 |
| IT8648203A0 (it) | 1986-06-30 |
| DK333787D0 (da) | 1987-06-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPH08500589A (ja) | アストラガルス ポリサッカライド免疫調節剤 | |
| LU85974A1 (fr) | Melange de gangliosides utile comme instrument therapeutique d'elimination d'effets douloureux de neuropathies peripheriques | |
| US4940694A (en) | Therapeutic use of GM1 in severe cerebral ischemic strokes pathologies | |
| Manik et al. | Anti-diabetic and antihyperlipidemic effect of allopolyherbal formulation in OGTT and STZ-induced diabetic rat model | |
| LU86930A1 (fr) | Utilisation de gangliosides exogenes dens des maladies tumorales comme facteur de protection contre la toxite de medicaments antitumoraux | |
| CA2749931C (en) | Use of pterosin compounds for treating diabetes and obesity | |
| EP2931295B1 (fr) | Extrait d'algues comprenant des polysaccharides polyanioniques sulfatés et non sulfatés et ses applications | |
| US4910224A (en) | Method of modifying the lipid structure and function of cell membranes and pharmaceutical compositions for use therein | |
| CA3090394A1 (en) | Methods for treating mitochondrial disorders | |
| Reynolds et al. | Dopamine metabolism in human brain: effects of monoamine oxidase inhibition in vitro by (—) deprenyl and (+) and (—) tranylcypromine | |
| CA2045982A1 (en) | Use of the gm monosialoganglioside and of its internal ester derivative to prevent the insurgence in man of the | |
| DE69330842T2 (de) | Verwendung von Monosialogangliosid GMl oder von N-Dichlor-Acetyl-lyso-GMl zur Vorbeugung oder zur Umkehrung der von einer Langzeitbehandlung mit L-DOPA bei der Therapie von Morbus Parkinson induzierten neuronale Degeneration | |
| EP1035858A1 (fr) | Utilisation d'extraits de ginkgo biloba pour preparer un medicament | |
| EP1207878B1 (de) | Behandlung der migräne durch verabreichung von alpha-liponsäure oder derivaten derselben | |
| US20030143282A1 (en) | Adenosine A3 receptor agonist | |
| CA2716764C (fr) | Nouvelle utilisation de n-acetyl-taurinate de zinc | |
| Zeldowicz et al. | Long-term therapy of Parkinson's disease with amantadine, alone and combined with levodopa | |
| GRECO et al. | Cycloleucine encephalopathy | |
| Samson | GM1 ganglioside treatment of central nervous system injury: Clinical evidence for improved recovery | |
| KR100485936B1 (ko) | 진세노사이드 Rh2 및 Rg3 항암 조성물 | |
| DE102006019907A1 (de) | Verwendung von substituierten Glycerinderivaten zur Herstellung einer pharmazeutischen Zubereitung | |
| Jiang et al. | Roles and mechanisms of fucoidan against dermatitis: A review | |
| IMAMOTO et al. | Effect of neonatal administrations of 6-OHDA on the brain development I. Alteration in the striatum | |
| EP0493861A2 (de) | Nicotinamid-adenin-dinukleodid enthaltendes Antidepressionsmittel | |
| Rybalkina et al. | Correction of the toxic effect of cyclophosphamide on hemopoiesis in animals with lewis lung carcinoma using low-molecular-weight sodium alginate |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| DT | Application date | ||
| TA | Annual fee |